Jiang Zhong Pharmaceutical Co.,Ltd (SHA: 600750)
China
· Delayed Price · Currency is CNY 21.17
-0.04 (-0.19%)
Sep 6, 2024, 3:00 PM CST
Jiang Zhong Pharmaceutical Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 4,179 | 4,364 | 3,846 | 2,856 | 2,435 | 2,444 | Upgrade
|
| Other Revenue | 22.05 | 26.21 | 39.58 | 17.88 | 6.9 | 5.9 | Upgrade
|
| Revenue | 4,201 | 4,390 | 3,885 | 2,874 | 2,441 | 2,449 | Upgrade
|
| Revenue Growth (YoY) | -3.35% | 13.00% | 35.19% | 17.72% | -0.32% | 39.55% | Upgrade
|
| Cost of Revenue | 1,432 | 1,532 | 1,384 | 1,026 | 847.82 | 819.37 | Upgrade
|
| Gross Profit | 2,769 | 2,858 | 2,501 | 1,848 | 1,594 | 1,630 | Upgrade
|
| Selling, General & Admin | 1,693 | 1,839 | 1,713 | 1,196 | 962.24 | 1,036 | Upgrade
|
| Research & Development | 152.64 | 133.33 | 99.97 | 87.82 | 55.55 | 47.51 | Upgrade
|
| Other Operating Expenses | 72.36 | 55.4 | 59.31 | 52.48 | 45.71 | 47.92 | Upgrade
|
| Operating Expenses | 1,918 | 2,026 | 1,874 | 1,336 | 1,065 | 1,128 | Upgrade
|
| Operating Income | 850.47 | 832.43 | 626.7 | 511.29 | 528.48 | 501.75 | Upgrade
|
| Interest Expense | -3.84 | -6.98 | -4.38 | -3.46 | -1.93 | - | Upgrade
|
| Interest & Investment Income | 78.69 | 67.64 | 37 | 26.3 | 15.27 | 25.78 | Upgrade
|
| Other Non Operating Income (Expenses) | 12.52 | -3.58 | -12.33 | -8.77 | -0.06 | 7.32 | Upgrade
|
| EBT Excluding Unusual Items | 937.85 | 889.51 | 646.99 | 525.36 | 541.75 | 534.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | -57.69 | -40.05 | 57.1 | 51.25 | -15.85 | 13.27 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.28 | 1.22 | -0.13 | 0.9 | -0.21 | -0.98 | Upgrade
|
| Asset Writedown | -2.53 | -2.01 | - | - | - | - | Upgrade
|
| Other Unusual Items | 72.76 | 48.47 | 49.32 | 45.63 | 53.7 | 18.87 | Upgrade
|
| Pretax Income | 951.68 | 897.13 | 753.28 | 623.14 | 579.4 | 566 | Upgrade
|
| Income Tax Expense | 137.53 | 130.47 | 106.89 | 92.19 | 89.07 | 86.56 | Upgrade
|
| Earnings From Continuing Operations | 814.15 | 766.66 | 646.39 | 530.95 | 490.32 | 479.44 | Upgrade
|
| Net Income to Company | 814.15 | 766.66 | 646.39 | 530.95 | 490.32 | 479.44 | Upgrade
|
| Minority Interest in Earnings | -66.9 | -58.37 | -48.15 | -25.26 | -16.58 | -15.84 | Upgrade
|
| Net Income | 747.25 | 708.29 | 598.24 | 505.69 | 473.74 | 463.6 | Upgrade
|
| Net Income to Common | 747.25 | 708.29 | 598.24 | 505.69 | 473.74 | 463.6 | Upgrade
|
| Net Income Growth | 13.95% | 18.40% | 18.30% | 6.74% | 2.19% | -1.41% | Upgrade
|
| Shares Outstanding (Basic) | 633 | 632 | 630 | 632 | 632 | 626 | Upgrade
|
| Shares Outstanding (Diluted) | 633 | 632 | 630 | 632 | 632 | 626 | Upgrade
|
| Shares Change (YoY) | 1.22% | 0.42% | -0.38% | 0.07% | 0.83% | -0.08% | Upgrade
|
| EPS (Basic) | 1.18 | 1.12 | 0.95 | 0.80 | 0.75 | 0.74 | Upgrade
|
| EPS (Diluted) | 1.18 | 1.12 | 0.95 | 0.80 | 0.75 | 0.74 | Upgrade
|
| EPS Growth | 12.58% | 17.89% | 18.75% | 6.67% | 1.35% | -1.33% | Upgrade
|
| Free Cash Flow | 768.07 | 827.02 | 676.02 | 728.55 | 569.97 | 564.85 | Upgrade
|
| Free Cash Flow Per Share | 1.21 | 1.31 | 1.07 | 1.15 | 0.90 | 0.90 | Upgrade
|
| Dividend Per Share | 1.800 | 1.300 | 1.150 | 0.650 | 0.270 | 0.250 | Upgrade
|
| Dividend Growth | 56.52% | 13.04% | 76.92% | 140.74% | 8.00% | 7.11% | Upgrade
|
| Gross Margin | 65.91% | 65.11% | 64.37% | 64.29% | 65.27% | 66.55% | Upgrade
|
| Operating Margin | 20.25% | 18.96% | 16.13% | 17.79% | 21.65% | 20.48% | Upgrade
|
| Profit Margin | 17.79% | 16.13% | 15.40% | 17.60% | 19.40% | 18.93% | Upgrade
|
| Free Cash Flow Margin | 18.28% | 18.84% | 17.40% | 25.35% | 23.35% | 23.06% | Upgrade
|
| EBITDA | 971.92 | 949.21 | 746.78 | 626.2 | 641.24 | 614.72 | Upgrade
|
| EBITDA Margin | 23.14% | 21.62% | 19.22% | 21.79% | 26.26% | 25.10% | Upgrade
|
| D&A For EBITDA | 121.45 | 116.79 | 120.08 | 114.91 | 112.77 | 112.97 | Upgrade
|
| EBIT | 850.47 | 832.43 | 626.7 | 511.29 | 528.48 | 501.75 | Upgrade
|
| EBIT Margin | 20.25% | 18.96% | 16.13% | 17.79% | 21.65% | 20.48% | Upgrade
|
| Effective Tax Rate | 14.45% | 14.54% | 14.19% | 14.79% | 15.37% | 15.29% | Upgrade
|
| Revenue as Reported | 4,201 | 4,390 | 3,885 | 2,874 | 2,441 | 2,449 | Upgrade
|
| Advertising Expenses | - | 404.91 | 318.77 | 321.22 | 255.89 | 255.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.